|
References
|
1
|
The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995;333:1581-1587.
back
|
|
2
|
Grond M, Von Kummer R, Sobesky J. et al. Early x-ray hypoattenuation of brain parenchyma indicates extended critical hypoperfusion in acute astoke. Stroke 2000; 31:133-139.
back
|
|
3
|
Wintermark M, Thiran JP, Maeder P, et al. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. Am J Neuroradiol 2001; 22:905-914.
back
|
|
4
|
Wintermark M, Maeder P, Thiran JP, et al. Quantitative assessment of regional cerebral blood flow by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol 2001; 11:1220-1230.
back
|
|
5
|
Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998; 18:583-609.
back
|
|
6
|
Schlaug G, Benfield A, Baird AE, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999; 53:1528-1537.
back
|
|
7
|
Read SJ, Hirano T, Abbott DF, et al. The fate of hypoxic tissue on 18F-fluromisonidazole positron emission tomography after ischemic stroke. Ann Neurol 2000; 48:228-235.
back
|
|
8
|
Baron JC. Mapping the ischemic penumbra with PET: a new approach. Brain 2001; 124:2-4.
back
|
|
9
|
Migneco 0, Mena I, Villanueva-Meyer J. Semiquantitative HMPAO brain SPECT display: Validation of a high specificity colorscale threshold. Clin Nuc Med 1992; 17(9):767.
back
|
|
10
|
Lassen NA. Cerebral blood flow tomography with xenon-133. Semin Nucl Med 1985; 15:347-356.Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracranial hemorrage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679-1685
back
|
|
11
|
Warach S. Tissue viability thresholds in acute stroke: the 4-factor model. Stroke 2001; 32:2460-2461.
back
|
|
12
|
Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999; 30:34-39.
back
|
|
13
|
Von Kummer R, Bourquain H, Bastianello S, et al. Early predicton of irreversible brain damage after ischemic stroke at CT. Radiology 2001; 219:95-100.
back
|
|
14
|
Von Kummer R. Early major ischemic changes on computed tomography should preclude use of tissue plasminogen activator. Stroke 2003; 34:820-821.
back
|
|
15
|
Parsons MW, Barber PA, Chalk J, et al. Diffusion-and perfusion weighted MRI response to thrombolysis in stroke. Ann Neurol 2002; 51:28-37
back
|
|
|
